Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 26.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 67.50p
  • 52 Week Low: 10.25p
  • Currency: UK Pounds
  • Shares Issued: 125.28m
  • Volume: 58,732
  • Market Cap: £32.57m
  • RiskGrade: 594

Latest ShareCast News

Sareum shares rise on China patent allowance

By Josh White

Date: Monday 16 Sep 2024

(Sharecast News) - Cambridge-based biotechnology firm Sareum Holdings announced on Monday that it has received a notice of allowance from the China National Intellectual Property Administration for its patent application concerning crystalline forms of SDC-1801.

Sareum announces positive results from kinase inhibitor trial

By Josh White

Date: Monday 01 Jul 2024

(Sharecast News) - Sareum Holdings announced positive topline results from its phase 1a clinical trial of SDC-1801, a dual TYK2/JAK1 kinase inhibitor under development for treating autoimmune diseases.

Sareum allowed European patent for primary kinase inhibitor asset

By Josh White

Date: Friday 15 Mar 2024

(Sharecast News) - Biotechnology company Sareum announced on Friday that the European Patent Office had issued a notice of allowance for a patent concerning SDC‐1801, its primary TYK2/JAK1 kinase inhibitor currently undergoing clinical trials in Australia.

Sareum reports positive progress in psoriasis pr... 15-Feb-2024 ShareCast
Sareum shares jump on cancer drug licensing deal 02-Jan-2024 ShareCast
Sareum secures Japan patent for kinase inhibitor... 03-Nov-2023 ShareCast
Sareum losses widen as clinical trials continue 09-Oct-2023 ShareCast
Director dealings: Blackbird, Sareum insiders pi... 06-Sep-2023 ShareCast
Sareum granted new patents in China, US 26-Jun-2023 ShareCast
Sareum gets approval for phase one psoriasis stu... 05-May-2023 ShareCast
Sareum looks at options as GSK division returns ... 06-Mar-2023 ShareCast
Sareum confident despite recent setbacks 16-Dec-2022 ShareCast
Sareum progresses Covid-19 and autoimmune treatm... 16-Mar-2022 ShareCast
Sareum expects FY losses to widen on higher R&D ... 19-Aug-2021 ShareCast
Sareum positive on SRA737 outlook after Sierra c... 06-Aug-2021 ShareCast
Sareum releases 'encouraging' results from Covid... 01-Jul-2021 ShareCast
Sareum's pre-clinical development of SDC-1801 de... 25-May-2021 ShareCast
Sareum gets approval for US patent application 07-Jan-2021 ShareCast
Sareum Holdings secures grant for Covid-19 treat... 03-Dec-2020 ShareCast
Sareum gets conditional approval for UKRI grant 27-Oct-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 26.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 67.50p
52 Week Low 10.25p
Volume 58,732
Shares Issued 125.28m
Market Cap £32.57m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.66% below the market average51.66% below the market average51.66% below the market average51.66% below the market average51.66% below the market average
4% below the sector average4% below the sector average4% below the sector average4% below the sector average4% below the sector average
Price Trend
81.2% below the market average81.2% below the market average81.2% below the market average81.2% below the market average81.2% below the market average
59.18% below the sector average59.18% below the sector average59.18% below the sector average59.18% below the sector average59.18% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:28 3,500 @ 26.34p
16:00 2,907 @ 25.41p
15:53 247 @ 25.31p
15:43 1,080 @ 25.35p
13:51 18 @ 27.00p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page